This position statement from the Heart Failure Association of the European Society of
Cardiology Cardio‐Oncology Study Group in collaboration with the International Cardio …

The considerable progress made in the field of cancer treatment has led to a dramatic
improvement in the prognosis of patients with cancer. However, toxicities resulting from …

Aims The actual usefulness of cardiovascular (CV) risk factor assessment in the prognostic
evaluation of cancer patients treated with cardiotoxic treatment remains largely unknown …

Abstract The discipline of Cardio-Oncology has seen tremendous growth over the past
decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the …

Modern treatment strategies have led to improvements in cancer survival, however, these
gains might be offset by the potential negative effect of cancer therapy on cardiovascular …

Advances in cancer treatments have improved clinical outcomes, leading to an increasing
population of cancer survivors. However, this success is associated with high rates of short …

Advances in cancer screening and improved treatment approaches have led to an increase
in survivorship and, consequently, recognition of an association between cancer treatments …

The reductions in mortality and morbidity being achieved among cancer patients with current
therapies represent a major achievement. However, given their mechanisms of action, many …

Cardiotoxicity due to cancer treatment is of rising concern, for both cardiologists and
oncologists, because it may have a significant impact on cancer patient management and …

Improvements in treatment and earlier diagnosis have both contributed to increased survival
for many cancer patients. Unfortunately, many treatments carry a risk of late effects including …